AREV Life Sciences Global Corp. engages in the production and development of natural health and cannabis infused products. The company is headquartered in Coquitlam, British Columbia. The company produces ingredients and formulates therapeutic interventions in clinical nutrition, supplements, topicals and rational drug design, based on science. Its nutraceutical product formulations are sold under its BARE and Wright and Well brands. Its BARE and Wright and Well Brands of finished products include natural health products, including cannabidiol (CBD)-infused products such as Canna-Mulsion and NaturVax, an anti-viral supplement; NaturRelax, a natural Sleep Aid; Natur Relief, an anti-inflator and pain relief product, and a line of CBD skincare products and medicinal oils and edibles. Its Ready-to-Use Therapeutic Food (RUTF) for Severe Acute Malnutrition (SAM), with its branded RUTF known as SUS-TAINN (Superior Utility Supplementation Therapeutic Agent for Indicated Nutritional Needs), and RESTORE is under development.
AREVF stock price ended at $0 on 木曜日, after rising NaN%
On the latest trading day Dec 18, 2025, the stock price of AREVF rose by NaN%, climbing from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. Notably, trading volume dropped by 48.0K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 50.0K shares were traded, equating to a market value of approximately --.